New patent expiration for Teva Branded drug SEASONIQUE – DrugPatentWatch
Annual Drug Patent Expiration for SEASONIQUE
Seasonique is a drug marketed by Teva Branded Pharm and included in one NDA. It is available from two suppliers. There are four patents protecting this drug and one Paragraph IV challenge.
Trends in drug prices SEASONIQUE.
Drug patent litigation for SEASONIQUE.
This drug has sixty patent family members in twenty-two countries.
The generic ingredient in SEASONIQUE is ethinyl estradiol; levonorgestrel. Two registered suppliers for this compound. Additional details are available on ethinyl estradiol; levonorgestrel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published on New patent expiration date for the drug Teva Branded SEASONIQUE
